![Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference](https://www.degruyter.com/document/doi/10.1515/cclm-2021-0399/asset/graphic/j_cclm-2021-0399_fig_002.jpg)
Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference
![PDF) Introduction of a Capillary Gel Electrophoresis-Based Workflow for Biotherapeutics Characterization: Size, Charge, and N-Glycosylation Variant Analysis of Bamlanivimab, an Anti-SARS-CoV-2 Product PDF) Introduction of a Capillary Gel Electrophoresis-Based Workflow for Biotherapeutics Characterization: Size, Charge, and N-Glycosylation Variant Analysis of Bamlanivimab, an Anti-SARS-CoV-2 Product](https://www.researchgate.net/publication/359114808/figure/fig3/AS:1131746087178241@1646840702719/cIEF-analysis-of-bamlanivimab-Section-a-Basic-peaks-Section-b-Main-peak-Section-c_Q320.jpg)
PDF) Introduction of a Capillary Gel Electrophoresis-Based Workflow for Biotherapeutics Characterization: Size, Charge, and N-Glycosylation Variant Analysis of Bamlanivimab, an Anti-SARS-CoV-2 Product
![PDF) Introduction of a Capillary Gel Electrophoresis-Based Workflow for Biotherapeutics Characterization: Size, Charge, and N-Glycosylation Variant Analysis of Bamlanivimab, an Anti-SARS-CoV-2 Product PDF) Introduction of a Capillary Gel Electrophoresis-Based Workflow for Biotherapeutics Characterization: Size, Charge, and N-Glycosylation Variant Analysis of Bamlanivimab, an Anti-SARS-CoV-2 Product](https://www.researchgate.net/publication/359114808/figure/fig4/AS:1131746087178242@1646840702757/N-glycan-profiling-A-and-sequencing-B-of-bamlanivimab-with-CGE-LIF-Peaks-as_Q320.jpg)